Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by the pharma giant to accelerate the use of artificial intelligence in diagnostic algorithms.

Why Your Lean Team is Losing to the Algorithm If you are operating as a lean team—or striving to be an “all-around super individual” handling strategy while executing at scale—the TikTok content ...

How are ordinary people drawn into extremist circles—and what role can artificial intelligence play in that process? This ...

New integration delivers dynamic ride pricing, improved CSI, and a proven path to higher RO spend -- all without sacrificing the customer experience ...

It is never easy to find the true cost of any ticket, especially in Delta One, where prices can vary so massively. Here is ...

Abstract: To address the problems of long computation time, low efficiency, and poor path quality in the autonomous path planning of path-finding robots in complex environments, a path planning method ...

ZURICH, May 7 (Reuters) - Swiss pharmaceutical giant Roche said on Thursday it had agreed to acquire U.S.-based digital pathology and AI-powered technology firm PathAI in a deal worth $750 million ...

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.

Fitbit Air costs $99 with no required subscription. Whoop 5.0 starts at $199/year. We break down which screenless tracker is ...